Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 4Phase 4 3Phase 1/2 2

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 2Bowen's Disease 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × methyl 5-aminolevulinate × Clear all
NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed
250 enrolled

Bowen's Disease

NCT03511326 2021-02-18

SESAME 2

Galderma R&D

Phase 4 Completed
50 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT02464709 2019-08-28

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
72 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡